Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Agile Therapeutics

NASDAQ AGRX
$0.38 0.0005 0.13%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.11M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
627.85K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.02
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
2.96M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-80.74 %

Upcoming events Agile Therapeutics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Agile Therapeutics

Stock analysis Agile Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.09 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.07 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.03 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.02 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
77.75 9.54

Price change Agile Therapeutics per year

0.91$ 3.77$
Min Max

Summary analysis Agile Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Agile Therapeutics

Revenue and net income Agile Therapeutics

All parameters

Stock news Agile Therapeutics

All news
22 March 2023 в 23:56

Agile Therapeutics Shares Surge 25% on Narrower Loss, Rev Boost

27 April 2022 в 20:40

Agile Therapeutics Shares Down 29% After Reverse Stock Split

27 April 2022 в 20:35

Agile Therapeutics Shares Down 29% After Reverse Stock Split

8 October 2021 в 20:30

Agile Therapeutics Shares Drop 29% After Public Stock Offering Prices

8 October 2021 в 20:25

Agile Therapeutics Shares Drop 29% After Public Stock Offering Prices

8 October 2021 в 15:50

Agile Therapeutics Prices Public Offering of Shares, Warrants

8 October 2021 в 15:50

Agile Therapeutics Prices Public Offering of Shares, Warrants

8 October 2021 в 00:45

Agile Therapeutics Plans Underwritten Public Offering, Shares 19% Lower

8 October 2021 в 00:45

Agile Therapeutics Plans Underwritten Public Offering, Shares 19% Lower

20 August 2021 в 17:59

Agile Therapeutics Works with Telehealth Service to Increase Women's Access to Twirla

20 August 2021 в 17:59

Agile Therapeutics Works with Telehealth Service to Increase Women's Access to Twirla

2 August 2021 в 18:49

Agile Therapeutics stock price target cut to $4 from $6 at Maxim

About company Agile Therapeutics

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Address:
101 Poor Farm Road, Princeton, NJ, United States, 08540
Company name: Agile Therapeutics
Issuer ticker: AGRX
ISIN: US00847L1008
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-05-23
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.agiletherapeutics.com

On which stock exchange are Agile Therapeutics (AGRX) stocks traded?

Agile Therapeutics (AGRX) stocks are traded on NASDAQ.

What is the ticker of Agile Therapeutics stocks (AGRX)?

The stock ticker of Agile Therapeutics’s stocks or in other words, the code is AGRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Agile Therapeutics (AGRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Agile Therapeutics (AGRX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Agile Therapeutics (AGRX) stocks traded?

Agile Therapeutics (AGRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Agile Therapeutics (AGRX) stocks today?

The current price of Agile Therapeutics stocks on 14.05.2024 is 0.3755 dollars. per share.

What is the dynamics of Agile Therapeutics (AGRX) stocks from the beginning of the year?

Agile Therapeutics (AGRX) quotes have increased by -79.59% from the beginning of the year up to 0.3755 dollars. per 1 stocks.

How much did Agile Therapeutics (AGRX) stocks increase in мае 2024?

This month Agile Therapeutics (AGRX) quotes have increased by -14.56% to 0.3755 dollars. per share.

How much are Agile Therapeutics (AGRX) stocks worth?

Today, on October, 14.05.2024 Agile Therapeutics’s (AGRX) stocks cost 0.3755 dollars..

What is the market capitalization of Agile Therapeutics (AGRX)?

Capitalization is the market value of Agile Therapeutics (AGRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Agile Therapeutics (AGRX) is estimated at about 1112853 dollars.